Sapien 3 Embolization From Ventricle to Aorta in the Setting of Noncalcified Aortic Regurgitation

Transcatheter aortic valve replacement is currently used off-label for noncalcified aortic valve regurgitation and therefore is restricted to selected cases. In this setting we describe a rare complication of Sapien 3 (Edwards Lifesciences, Irvine, California) embolization from the left ventricle to...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Ruz, Robin, Plessis, Julien, Guimbretiere, Guillaume, Roussel, Jean-Christian, Piriou, Pierre-Guillaume, Cueff, Caroline, Maurel, Blandine, Letocart, Vincent, Manigold, Thibaut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Mini-Focus Issue: Procedural Complications: Part 2
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305676/
https://www.ncbi.nlm.nih.gov/pubmed/34317470
http://dx.doi.org/10.1016/j.jaccas.2020.11.024
Descripción
Sumario:Transcatheter aortic valve replacement is currently used off-label for noncalcified aortic valve regurgitation and therefore is restricted to selected cases. In this setting we describe a rare complication of Sapien 3 (Edwards Lifesciences, Irvine, California) embolization from the left ventricle to the descending aorta. Given their technical challenges, such procedures require specific considerations and management. (Level of Difficulty: Advanced.)

Ejemplares similares